November 04, 2019 SITC 2019 preview – Pieris joins the quest for a better Herceptin Any signs of efficacy with PRS-343 could help Pieris claw back some of its recent losses, but Her2 targeting is increasingly competitive.
September 10, 2019 Esmo 2019 preview – immunotherapies grab the rest of the late-breaker focus Away from the main small-molecule focus of this year’s Esmo meeting, Keytruda flies the flag for immuno-oncology, including in a little-noticed mesothelioma study.
July 05, 2017 Biotech floats come back with a vengeance The biotech IPO market records its first billion dollar quarter in two years as demand for new issues recovers.